December 5, 2023

Bioniq Welcomes Emma Thornton, Former Nike and Weight Watchers VP, to its Advisory Board

Bioniq is thrilled to announce the newest addition to our Advisory Board: Emma Thornton, a luminary in global marketing and brand strategy with a rich background in luxury, sports, health, and beauty sectors.

Bioniq is thrilled to announce the newest addition to our Advisory Board: Emma Thornton, a luminary in global marketing and brand strategy with a rich background in luxury, sports, health, and beauty sectors. Emma's illustrious career includes transformative roles at Nike, where she was the Head of Strategy, Influencer Marketing and Athletes, Weight Watchers as Vice President as well as Chanel.

Emma brings to Bioniq a treasure trove of experience, having spearheaded Nike's Global Strategy for the Rio Olympics, which culminated in a $1.8 billion success story, and having led the global influencer marketing strategy that brought cultural icons like Drake, Travis Scott and Kendrick Lamar into the Nike family. Her strategic partnerships have redefined business models, melding culture with commerce to drive innovation and brand affinity.

At the heart of her expertise lies a profound understanding of consumer engagement, demonstrated through her work in creating highly engaged digital and physical communities that foster 1:1 relationships at scale. Her focus on full-funnel performance optimization, product innovation, and leadership development aligns seamlessly with Bioniq's mission to revolutionize health and wellness through personalized solutions.

Emma's vision for Bioniq is clear: "Bioniq's personalized health approach represents the future of wellness. Their commitment to fostering individual health journeys through innovation and data analytics resonates with my belief in creating engaged, empowered communities. I am excited to contribute to a brand that truly values individuality and delivers sustainable, long-term value to its clients."

With Emma on board, Bioniq reaffirms its dedication to pioneering a health revolution that is as unique as each person we serve.

Choose your Bioniq

Read more

Heart Health
February 24, 2025

Calcium for a Healthy Heart: Benefits & Sources

Calcium is crucial not just for strong bones, but also for a healthy heart. This essential mineral plays a vital role in regulating heartbeat, supporting blood clotting, maintaining healthy blood pressure, and strengthening heart muscle. A calcium deficiency can lead to various health issues, including irregular heartbeat and muscle problems. Ensure you're getting enough calcium through a balanced diet rich in dairy, leafy greens, and fortified foods, along with adequate vitamin D for proper absorption. Consult your doctor before taking supplements. Prioritizing calcium intake is a key step in maintaining cardiovascular wellness.
Heart Health
February 12, 2025

Magnesium for Heart Health

Magnesium is essential for heart health, playing a key role in regulating heartbeat, controlling blood pressure, maintaining healthy cholesterol levels, and preventing blood clots. A magnesium deficiency can lead to muscle cramps, fatigue, anxiety, high blood pressure, and irregular heartbeat. Factors like poor diet, digestive issues, certain medications, and excessive alcohol consumption can contribute to low magnesium levels. Boosting magnesium intake through a diet rich in leafy greens, nuts, seeds, and whole grains, or via supplements (after consulting a doctor), can significantly improve cardiovascular health and overall well-being.
Press
March 18, 2025

Manchester United’s Diogo Dalot Invests Over €1M in Bioniq, Joining Cristiano Ronaldo

London, February 25, 2025 – Bioniq, founded in 2019 and renowned for its personalized nutritional supplements based on blood biomarker data, is proud to announce that football star Diogo Dalot, right-back for Manchester United and the Portugal national team, has joined the company as an investor, contributing over €1 million. Dalot joins the global football icon Cristiano Ronaldo, who became a major investor in 2024, and brought Bioniq’s total valuation to $82 million. Dalot’s investment marks another milestone in Bioniq’s mission to make personalized health accessible to athletes and everyday individuals worldwide.